Accenture (ACN) Form 4: Arun Sarin adds RSUs, holds 8,478 shares

Rhea-AI Filing Summary

Accenture plc (ACN) reported that director Arun Sarin received a grant of 5 Class A ordinary shares in the form of restricted share units. The grant was made pursuant to anti-dilution provisions in previously granted RSU awards to reflect Accenture’s payment of a cash dividend, and carried a stated price of $0. Following this adjustment, Sarin beneficially owns 8,478 Class A ordinary shares in the company, held directly. This filing reflects a routine, small equity adjustment rather than a market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sarin Arun

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares	5	$0.00	--

Holdings After Transaction: Class A ordinary shares — 8,478 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sarin Arun

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	11/14/2025		A		5(1)	A	$0	8,478	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-In-Fact for Arun Sarin	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Accenture (ACN) report for Arun Sarin?

Accenture (ACN) reported that director Arun Sarin received a grant of 5 restricted share units (RSUs) representing Class A ordinary shares.

How many Accenture (ACN) shares does Arun Sarin now beneficially own?

After the reported RSU grant, Arun Sarin beneficially owns 8,478 Accenture Class A ordinary shares, held directly.

What type of security was involved in the Accenture (ACN) Form 4 filing?

The Form 4 shows Class A ordinary shares of Accenture, received through a grant of restricted share units (RSUs).

Why were the restricted share units granted to the Accenture (ACN) director?

The RSUs were granted under the anti-dilution provisions of prior RSU awards to reflect Accenture plc’s payment of a cash dividend.

Was the Accenture (ACN) insider transaction an open market purchase or sale?

No. The filing describes a grant of RSUs at a stated price of $0, not an open market purchase or sale of Accenture shares.

What is the transaction date for the Accenture (ACN) RSU grant to Arun Sarin?

The earliest transaction date reported for the RSU grant to Arun Sarin is 11/14/2025.